Infrared metabolism. Targeted cryotherapy. Clinical DEXA. Sequenced around your body, not a standard menu.
What we offer
Three clinical assessments and six treatments, in one studio, so the numbers and the protocol stay in the same place.
Bone density, lean mass, regional fat and visceral fat. The reference standard.
Your actual calorie burn, measured breath by breath. Not a formula’s guess.
Aerobic capacity and your real training zones, measured at maximum effort.
30% less fat, 25% more muscle across a four-session course.*
Controlled cooling with EMS for a targeted, stubborn area.
Six recovery therapies at once. Thirty passive minutes.
Full-body sequential compression. Forty-five touchless minutes.
EMSCULPT NEO functional protocols — muscle re-education, mobility, joint support.
*Average results in the treated area from published clinical studies of HIFEM+RF. Individual results vary and are not guaranteed.
How they combine
Infrared raises core temperature, drops inflammation, and primes the system for change.
Cold crystallizes fat cells in the priority zones flagged by DEXA.
Re-scan at 8–12 weeks. The data closes the loop.
Cross-modality FAQ
We’re the only studio in Orange County where you can measure and treat in the same visit. Every plan starts with a clinical DEXA scan; treatments are sequenced around your results, not a standard menu.
Yes. Our Precision Intro Session combines DEXA + ExoFreeze + ExoPod in a single visit, so we can establish your baseline and begin treatment the same day.
ExoPod infrared opens metabolism and reduces inflammation. ExoFreeze targets the fat zones identified by DEXA. DEXA then measures the change — closing the loop on whether the protocol worked.
All three modalities are non-invasive and FDA-cleared device categories. We screen every client for contraindications during your first visit and coordinate with your physician on referrals when needed.
Frequency depends on your goals. Most members come in 4–8 times per month across a combination of ExoPod, ExoFreeze, and DEXA milestones.